Patents by Inventor Matthew Drever

Matthew Drever has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems targeting PSMA and CA9
    Patent number: 12257304
    Abstract: Provided herein are antibodies and chimeric priming receptors that bind PSMA and antibodies and chimeric antigen receptors that bind CA9. Also provided are systems of chimeric priming receptors that bind PSMA and chimeric antigen receptors that bind CA9, cells expressing such systems, and methods of use thereof.
    Type: Grant
    Filed: March 1, 2024
    Date of Patent: March 25, 2025
    Assignee: Arsenal Biosciences, Inc.
    Inventors: Angela Boroughs, Levi Gray-Rupp, Samuel A. Williams, Zhen Jian Zhou, Matthew Drever, Duy Nguyen, Amy-Jo Casbon, Anzhi Yao, Thomas Gardner
  • PROSTATE CANCER CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20250066435
    Abstract: Provided are antibodies, fragments thereof, chimeric antigen receptors (CARs) and T cell receptors (TCRs) comprising one or more of the anti-PMCA antigen binding domains disclosed herein. SynNotch receptors that comprise an anti-PSCA binding domain Provided are polynucleotides encoding antibodies, fragments thereof, CARs, T cell receptors (TCR) and SynNotch receptors. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.
    Type: Application
    Filed: June 10, 2024
    Publication date: February 27, 2025
    Inventors: Matthew Drever, Amy E. Gilbert, Samuel T. Haile, Catherine A. Hartzell
  • SYSTEMS TARGETING PSMA AND CA9
    Publication number: 20240342284
    Abstract: Provided herein are antibodies and chimeric priming receptors that bind PSMA and antibodies and chimeric antigen receptors that bind CA9. Also provided are systems of chimeric priming receptors that bind PSMA and chimeric antigen receptors that bind CA9, cells expressing such systems, and methods of use thereof.
    Type: Application
    Filed: March 1, 2024
    Publication date: October 17, 2024
    Inventors: Angela Boroughs, Levi Gray-Rupp, Samuel A. Williams, Zhen Jian Zhou, Matthew Drever, Duy Nguyen, Amy-Jo Casbon, Anzhi Yao, Thomas Gardner
  • Prostate cancer chimeric antigen receptors
    Patent number: 12037605
    Abstract: Provided are antibodies, fragments thereof, chimeric antigen receptors (CARs) and T cell receptors (TCRs) comprising one or more of the anti-PMCA antigen binding domains disclosed herein. SynNotch receptors that comprise an anti-PSCA binding domain Provided are polynucleotides encoding antibodies, fragments thereof, CARs, T cell receptors (TCR) and SynNotch receptors. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: July 16, 2024
    Assignee: Kite Pharma, Inc.
    Inventors: Matthew Drever, Amy E. Gilbert, Samuel T. Haile, Catherine A. Hartzell
  • GPC3 BINDING MOLECULES
    Publication number: 20230020993
    Abstract: Provided are antibodies, fragments thereof, chimeric antigen receptors (CARs) and T cell receptors (TCRs) comprising one or more of the GPC3 binding domains disclosed herein. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.
    Type: Application
    Filed: June 7, 2022
    Publication date: January 19, 2023
    Inventors: Matthew Drever, Gabrielle M. Romain, Sarah K. Wyman, Chi Ying
  • TACI BINDING MOLECULES
    Publication number: 20220354892
    Abstract: Provided are antibodies, fragments thereof, chimeric antigen receptors (CARs) and T cell receptors (TCRs) comprising one or more of the dual TACI-BCMA binding domains disclosed herein. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.
    Type: Application
    Filed: March 25, 2022
    Publication date: November 10, 2022
    Inventors: Jonathan Belk, Raghavender Chivukula, Matthew Drever, Edward Hai Dhow Liao
  • PROSTATE CANCER CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20220204930
    Abstract: Provided are antibodies, fragments thereof, chimeric antigen receptors (CARs) and T cell receptors (TCRs) comprising one or more of the anti-PMCA antigen binding domains disclosed herein. SynNotch receptors that comprise an anti-PSCA binding domain Provided are polynucleotides encoding antibodies, fragments thereof, CARs, T cell receptors (TCR) and SynNotch receptors. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 30, 2022
    Inventors: Matthew Drever, Amy E. Gilbert, Samuel T. Haile, Catherine A. Hartzell